PMC:7352545 / 46442-47494
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T403 | 384-393 | Body_part | denotes | G protein | http://purl.org/sig/ont/fma/fma61788 |
T404 | 569-573 | Body_part | denotes | axis | http://purl.org/sig/ont/fma/fma12520 |
T405 | 700-708 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T406 | 762-766 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T407 | 807-817 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T20 | 201-207 | Body_part | denotes | organs | http://purl.obolibrary.org/obo/UBERON_0000062 |
T21 | 762-766 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T158 | 600-623 | Disease | denotes | cardiovascular diseases | http://purl.obolibrary.org/obo/MONDO_0004995 |
T159 | 680-688 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T160 | 767-773 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T638 | 201-207 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organs |
T639 | 214-217 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T640 | 256-257 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T641 | 275-280 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T642 | 291-299 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T643 | 384-410 | http://purl.obolibrary.org/obo/PR_000030035 | denotes | G protein-coupled receptor |
T644 | 412-416 | http://purl.obolibrary.org/obo/PR_000030035 | denotes | GPCR |
T645 | 425-433 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activate |
T646 | 523-532 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
T647 | 577-578 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T648 | 762-766 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T649 | 762-766 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T650 | 777-783 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | humans |
T651 | 798-799 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T652 | 807-825 | http://purl.obolibrary.org/obo/CHEBI_33708 | denotes | amino acid residue |
T653 | 807-825 | http://purl.obolibrary.org/obo/PR_000036907 | denotes | amino acid residue |
T654 | 1004-1007 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T655 | 1008-1009 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1446 | 12-23 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T1447 | 51-53 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1448 | 59-61 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1449 | 81-83 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1450 | 174-178 | Chemical | denotes | salt | http://purl.obolibrary.org/obo/CHEBI_24866|http://purl.obolibrary.org/obo/CHEBI_26710 |
T1452 | 307-309 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1453 | 386-393 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T1454 | 520-522 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1455 | 700-708 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T1456 | 721-723 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1457 | 807-825 | Chemical | denotes | amino acid residue | http://purl.obolibrary.org/obo/CHEBI_33708 |
T1458 | 807-817 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
T1459 | 807-812 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T1460 | 813-817 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T1461 | 835-837 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1462 | 851-862 | Chemical | denotes | vasodilator | http://purl.obolibrary.org/obo/CHEBI_35620 |
T1463 | 925-927 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T1464 | 1037-1051 | Chemical | denotes | ACE inhibitors | http://purl.obolibrary.org/obo/CHEBI_35457 |
T1465 | 1041-1051 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T72 | 143-159 | http://purl.obolibrary.org/obo/GO_0042310 | denotes | vasoconstriction |
T73 | 179-188 | http://purl.obolibrary.org/obo/GO_0051235 | denotes | retention |
T74 | 523-532 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T446 | 0-54 | Sentence | denotes | ACE cleaves angiotensin I (Ang I) substrate to Ang II. |
T447 | 55-208 | Sentence | denotes | Ang II recognizes the Ang II receptor type 1 (AT1R), contributing to systemic and local vasoconstriction, fibrosis and salt retention in vascular organs. |
T448 | 209-247 | Sentence | denotes | ACE2 has the opposite function of ACE. |
T449 | 248-285 | Sentence | denotes | ACE2 is a close homolog to human ACE. |
T450 | 286-354 | Sentence | denotes | ACE2 activity on Ang II is about 400-fold higher than that on Ang I. |
T451 | 355-533 | Sentence | denotes | Ang-1 to Ang-7 recognize the G protein-coupled receptor (GPCR) Mas to activate vasorelaxation, cardioprotection, antioxidative action, antiinflammation and anti-Ang II-signaling. |
T452 | 534-624 | Sentence | denotes | Therefore, the ACE2-Ang-1 to Ang-7 axis is a target candidate for cardiovascular diseases. |
T453 | 625-689 | Sentence | denotes | ACE2 shows similar binding structures between nCoV and SARS-CoV. |
T454 | 690-784 | Sentence | denotes | The three proteins of ACE, Ang II and AT1R contribute to progression of lung injury in humans. |
T455 | 785-882 | Sentence | denotes | ACE2 removes a single amino acid residue from Ang II to yield the vasodilator, named Ang 1-Ang 7. |
T456 | 883-946 | Sentence | denotes | ACE2 cleaves Ang-I to Ang 1–Ang 9 and Ang II to Ang-1 to Ang-7. |
T457 | 947-1052 | Sentence | denotes | The biggest difference between ACE2 and ACE is that ACE2 has a non-inhibitory property by ACE inhibitors. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T13 | 600-623 | Phenotype | denotes | cardiovascular diseases | http://purl.obolibrary.org/obo/HP_0001626 |